[go: up one dir, main page]

NO20055921L - Heterocykliske metylsulfonderivater - Google Patents

Heterocykliske metylsulfonderivater

Info

Publication number
NO20055921L
NO20055921L NO20055921A NO20055921A NO20055921L NO 20055921 L NO20055921 L NO 20055921L NO 20055921 A NO20055921 A NO 20055921A NO 20055921 A NO20055921 A NO 20055921A NO 20055921 L NO20055921 L NO 20055921L
Authority
NO
Norway
Prior art keywords
substituent
heterocyclic
methylsulfone
derivatives
heterocyclic group
Prior art date
Application number
NO20055921A
Other languages
English (en)
Inventor
Hideki Kubota
Takanori Yasukouchi
Kayoko Motoki
Masanori Saito
Hitoshi Iimori
Satoru Miyauchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20055921L publication Critical patent/NO20055921L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Det er tilveiebrakt en forbindelse som er i stand til inhibere produksjon eller sekresjon av P-amyloid-protein. Forbindelse representert ved den følgende formel (1): (hvor Rrepresenterer en heterocyklisk gruppe som kan ha en substituent, R2 representerer en cyklisk hydrokarbongruppe som kan ha en substituent eller en heterocyklisk gruppe som kan ha en substituent, Rrepresenterer en cyklisk hydrokarbongruppe som kan ha en substituent eller en heterocyklisk gruppe som kan ha en substituent, Rrepresenterer et hydrogenatom eller en C_alkylgnippe og X representerer -S-.-SO- eller -S0-); et N-oksyd eller S-oksyd derav; et salt derav; eller et solvat derav; og et medikament som inneholder hvilke som helst av disse.
NO20055921A 2003-06-30 2005-12-13 Heterocykliske metylsulfonderivater NO20055921L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003187796 2003-06-30
JP2004099151 2004-03-30
PCT/JP2004/009132 WO2005000798A1 (ja) 2003-06-30 2004-06-29 複素環メチルスルホン誘導体

Publications (1)

Publication Number Publication Date
NO20055921L true NO20055921L (no) 2006-01-24

Family

ID=33554493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055921A NO20055921L (no) 2003-06-30 2005-12-13 Heterocykliske metylsulfonderivater

Country Status (13)

Country Link
US (1) US7932271B2 (no)
EP (1) EP1640366A4 (no)
JP (1) JP4523914B2 (no)
KR (1) KR20060066057A (no)
AU (1) AU2004251987C1 (no)
CA (1) CA2526487A1 (no)
IL (1) IL172139A0 (no)
MX (1) MXPA05013631A (no)
NO (1) NO20055921L (no)
PL (1) PL379466A1 (no)
RU (1) RU2336270C2 (no)
TW (1) TWI328005B (no)
WO (1) WO2005000798A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0120347D0 (en) 2001-08-21 2001-10-17 Merck Sharp & Dohme Therapeutic agents
RU2304140C2 (ru) * 2001-12-27 2007-08-10 Дайити Фармасьютикал Ко., Лтд. ИНГИБИТОРЫ ПРОДУЦИРОВАНИЯ / СЕКРЕЦИИ β-АМИЛОИДНОГО БЕЛКА
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
WO2005000798A1 (ja) 2003-06-30 2005-01-06 Daiichi Pharmaceutical Co., Ltd. 複素環メチルスルホン誘導体
EP1867636B1 (en) * 2005-04-08 2013-06-05 Daiichi Sankyo Company, Limited Pyridylmethylsulfone derivative
RU2446158C9 (ru) * 2006-06-22 2012-06-20 Астразенека Аб Замещенные изоиндолы в качестве ингибиторов васе и их применение
JP2008115166A (ja) * 2006-10-10 2008-05-22 Daiichi Sankyo Co Ltd ピリジルフェニルメチルスルホン誘導体
BRPI0719379A2 (pt) * 2006-11-24 2014-02-11 Ac Immune Sa Composto, composição farmacêutica, uso de composto, mistura, métodos para coletar dados para o diagnóstico de uma doença ou condição associada com amilóide em uma amostra ou um paciente, para determinar a extensão da carga de placa amiloidogênica em um tecido e/ou um fluido corporal, para coletar dados para determinar a predisposição a uma doença ou condição associada com amilóide em um paciente, para coletar dados para monitorar a doença residual mínima em um paciente seguindo o tratamento com um anticorpo ou uma composição de vacina e para coletar dados para predizer a responsividade de um paciente sendo tratado com um anticorpo ou uma composição de vacina, e, kit de teste
TW200920362A (en) 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
ES2428326T3 (es) * 2007-10-04 2013-11-07 Merck Sharp & Dohme Corp. Derivados de aril sulfona sustituida como bloqueadores de canales de calcio
EP2311823A1 (en) 2009-10-15 2011-04-20 AC Immune S.A. 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
EP2593434A1 (en) 2010-07-16 2013-05-22 Purdue Pharma LP Pyridine compounds as sodium channel blockers
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
JP6726299B2 (ja) * 2016-03-30 2020-07-22 株式会社ニコン 硬化性組成物、硬化物、および、光学部材

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849423A (en) * 1971-03-22 1974-11-19 Lilly Co Eli 3-benzylpyridines
US4055652A (en) * 1975-07-07 1977-10-25 Syntex (U.S.A.) Inc. 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof
ZA765075B (en) 1975-09-25 1977-08-31 American Cyanamid Co Hypolipemic compounds and method of treatment
US4116665A (en) * 1976-04-02 1978-09-26 Eli Lilly And Company Method of regulating the growth of aquatic weeds with pyridine derivatives
FR2375228A1 (fr) * 1976-12-23 1978-07-21 Parcor Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants
DE2724684A1 (de) 1977-06-01 1978-12-14 Basf Ag Triazolsubstituierte schwefelverbindungen
DE2735314A1 (de) 1977-08-05 1979-02-22 Basf Ag Alpha-azolylsulfide und deren derivate
US4675316A (en) * 1978-03-10 1987-06-23 Rohm And Haas Company Substituted azoylmethylarylsulfides and derivatives and pesticidal use thereof
US4257954A (en) * 1978-08-08 1981-03-24 Sterling Drug Inc. Novel compounds, processes and marking systems
ZA794030B (en) * 1978-08-08 1980-07-30 Sterling Drug Inc Aryl sulfinic acid derivatives of aliphatic,aromatic or heterocyclic compounds
US4379921A (en) 1980-08-21 1983-04-12 Sumitomo Chemical Company, Limited Production of triazolylvinyl ketones
FR2509725A1 (fr) 1981-07-15 1983-01-21 Choay Sa (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant
EP0117485A3 (de) 1983-02-28 1985-01-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyridin-, Pyrazin- und Pyrimidinderivate und deren Verwendung als fungizide Wirkstoffe
DE3406908A1 (de) 1984-02-25 1985-09-05 Hoechst Ag, 6230 Frankfurt Neue triazolylalkylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenbehandlungsmittel
JPS6239563A (ja) 1985-08-13 1987-02-20 Hokko Chem Ind Co Ltd β−ニトロフエネチル誘導体および農園芸用殺菌剤
US5359078A (en) 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
DE4215437A1 (de) 1992-05-11 1993-11-18 Paul Prof Dr Messinger Darstellung von Alkylacylaten mit ß-ständigen elektronenziehenden Resten im Alkylteil
JPH0625168A (ja) * 1992-07-10 1994-02-01 Nippon Bayeragrochem Kk 殺菌性ベンジルピリジン類
JPH0656780A (ja) * 1992-08-01 1994-03-01 Nippon Bayeragrochem Kk 殺菌性α−置換ベンジルピリジン類
DE19521355A1 (de) * 1995-06-12 1996-12-19 Hoechst Schering Agrevo Gmbh Sulfonamide, Verfahren zu deren Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
JPH0995444A (ja) 1995-10-02 1997-04-08 Teijin Ltd アミロイド蛋白凝集阻害剤
DE69839305T2 (de) 1997-02-27 2009-04-09 Takeda Pharmaceutical Co. Ltd. Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
JP3868354B2 (ja) * 1997-02-27 2007-01-17 武田薬品工業株式会社 アミン誘導体、その製造法および剤
GB9902938D0 (en) * 1999-02-10 1999-03-31 Novartis Ag Organic compounds
IL144781A0 (en) 1999-02-26 2002-06-30 Merck & Co Inc Novel sulfonamide compounds and uses thereof
JP2003528076A (ja) 2000-03-20 2003-09-24 メルク シャープ エンド ドーム リミテッド スルホンアミド置換架橋ビシクロアルキル誘導体
US6951948B2 (en) 2000-06-05 2005-10-04 Ortho-Mcneil Pharmaceutical, Inc. Method for synthesis of substituted azole libraries
HUP0303857A3 (en) * 2000-12-13 2007-07-30 Wyeth Corp Heterocyclic sulifonamide inhibitors of beta amyloid production
GB0108592D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
PL372212A1 (en) 2001-08-03 2005-07-11 Schering Corporation Novel gamma secretase inhibitors
EP1411944A1 (en) 2001-08-03 2004-04-28 Schering Corporation Sulfonamide derivatives as gamma secretase inhibitors
JP3711131B2 (ja) 2001-08-21 2005-10-26 メルク シャープ エンド ドーム リミテッド 新規のシクロヘキシルスルホン
EP1465861B1 (en) 2001-12-20 2009-05-06 Bristol-Myers Squibb Company Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
RU2304140C2 (ru) * 2001-12-27 2007-08-10 Дайити Фармасьютикал Ко., Лтд. ИНГИБИТОРЫ ПРОДУЦИРОВАНИЯ / СЕКРЕЦИИ β-АМИЛОИДНОГО БЕЛКА
DE10201392A1 (de) 2002-01-16 2003-07-31 Bayer Ag Phenylsulfoxide und-sulfone
TW200302717A (en) 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
ATE435219T1 (de) 2002-05-01 2009-07-15 Merck Sharp & Dohme Heteroaryl substituierte spirocyclische sulfamide zur hemmung von gamma sekretase
GB0209995D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0209991D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0209997D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
SG143986A1 (en) 2002-06-11 2008-07-29 Wyeth Corp Substituted phenylsulfonamide inhibitors of beta amyloid production
EP1534291B1 (en) 2002-08-23 2008-11-12 Eli Lilly And Company 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223040D0 (en) * 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223038D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0225474D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
GB0225475D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
WO2005000798A1 (ja) 2003-06-30 2005-01-06 Daiichi Pharmaceutical Co., Ltd. 複素環メチルスルホン誘導体

Also Published As

Publication number Publication date
IL172139A0 (en) 2006-04-10
PL379466A1 (pl) 2006-09-18
TWI328005B (en) 2010-08-01
HK1090362A1 (zh) 2006-12-22
MXPA05013631A (es) 2006-02-24
EP1640366A1 (en) 2006-03-29
AU2004251987B2 (en) 2010-07-01
AU2004251987B8 (en) 2010-07-22
AU2004251987C1 (en) 2010-11-18
RU2005141552A (ru) 2006-06-27
AU2004251987A1 (en) 2005-01-06
EP1640366A4 (en) 2009-05-13
WO2005000798A1 (ja) 2005-01-06
KR20060066057A (ko) 2006-06-15
CA2526487A1 (en) 2005-01-06
JPWO2005000798A1 (ja) 2006-08-03
RU2336270C2 (ru) 2008-10-20
TW200523251A (en) 2005-07-16
JP4523914B2 (ja) 2010-08-11
US20060241302A1 (en) 2006-10-26
US7932271B2 (en) 2011-04-26

Similar Documents

Publication Publication Date Title
NO20055921L (no) Heterocykliske metylsulfonderivater
NO20081464L (no) 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer
NO20081551L (no) Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme
NO20060219L (no) Forbindelser
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
TW200633991A (en) Chemical compounds
NO20070457L (no) Pyrazolderivater
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
NO20065573L (no) Orto-substituerte aryl eller heteroarylamidforbindelser
WO2008078196A3 (en) Substituted heteroaryl pyridopyrimidone derivatives
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
NO20066015L (no) Fuserte heterosykliske forbindelser
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
WO2008136444A1 (ja) 縮合複素環誘導体
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
MY145746A (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
EA200971061A1 (ru) Пиримидоновые соединения гетероариламидов
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
NO20082698L (no) Nye derivater, deres salter og antisoppmidler inneholdende disse
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO20074346L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application